Somewhat Bearish -25

The Tesla Network Is Dead: JPMorgan’s Bombshell Note Reveals Nearly All Robotaxi Billions Flow to TSLA, Not You

📉 JPMorgan projects $320B in Tesla robotaxi revenue by 2035, with nearly all ($314B) flowing to a company-owned fleet rather than individual vehicle owners.

🚗 The 'Tesla Network' pitch for passive income from personal cars is effectively retired as the business model shifts to a capital-heavy mobility operator.

💰 Q2 FY2026 revenue reached $28.24B (+25.5% YoY), but non-GAAP EPS of $0.33 missed the $0.54 consensus estimate.

📉 Operating margin compressed to 1.4% and free cash flow turned negative at -$1.09B in Q2 FY2026.

📈 Robotaxi service now spans seven U.S. metros with 1.48 million active FSD subscriptions, up 56% YoY.

🏭 Cybercab production has begun at Gigafactory Texas to support the vertically integrated fleet strategy.

💸 CFO Vaibhav Taneja guided 2026 capital expenditures above $25 billion to fund aggressive fleet expansion.

📉 Stock price is down 18.74% year-to-date with a forward P/E of 152 and 18 downward analyst revisions in the last 30 days.

🚀 CEO Elon Musk stated demand will outstrip ability to service it, reinforcing the high-growth potential despite current cash burn.

⚖️ The revised thesis raises the long-term ceiling but increases the execution bar regarding production and regulatory approvals.

Bullish Signals
  • JPMorgan projects $320B in robotaxi revenue by 2035, with nearly all ($314B) flowing to a company-owned fleet rather than individual owners.
  • Robotaxi service spans seven U.S. metros with 1.48 million active FSD subscriptions, up 56% YoY.
  • CEO Elon Musk stated demand will outstrip the ability to service it, indicating strong market potential.
  • Cybercab production has begun at Gigafactory Texas, signaling progress on key hardware for the robotaxi network.
Risk Factors
  • Q2 operating margin compressed to 1.4% and free cash flow turned negative at -$1.09B.
  • Non-GAAP EPS of $0.33 missed the $0.54 consensus, reflecting near-term profitability challenges.
  • Stock is down 18.74% year-to-date with a forward P/E of 152 and 18 downward analyst revisions in the trailing 30 days.
  • The shift to a company-owned fleet model significantly raises capital intensity, requiring over $25B in 2026 capex.
Full Analysis
JPMorgan analyst Rajat Gupta released a significant note projecting that Tesla's robotaxi revenue will reach approximately $320 billion by 2035, with nearly all of that amount ($314 billion) flowing to a company-owned and operated fleet rather than individual vehicle owners. This analysis effectively retires the long-standing pitch for a customer-owned 'Tesla Network,' reframing the robotaxi opportunity as a capital-heavy mobility operator business similar to Waymo, where Tesla retains essentially all ride revenue while significantly raising capital intensity. Tesla reported Q2 FY2026 revenue of $28.24 billion, representing a 25.5% year-over-year increase, though non-GAAP EPS of $0.33 missed the $0.54 consensus. The company's robotaxi service currently spans seven U.S. metros with 1.48 million active FSD subscriptions up 56% year-over-year. CEO Elon Musk reinforced a vertically integrated strategy on the Q2 call, stating that demand will outstrip their ability to service it, aligning with the analyst view of rapid Cybercab production scaling at Gigafactory Texas. Financial metrics indicate a challenging near-term environment as Tesla's forward P/E stands at 152, stock price is down 18.74% year-to-date, and Q2 operating margin compressed to just 1.4%. Free cash flow turned negative at -$1.09 billion, signaling that the heavy investment cycle required for fleet expansion is already impacting reported results. Analyst consensus has drifted downward with 18 revisions against 7 upward over the trailing 30 days, though the revised thesis raises the long-term ceiling if execution on Cybercab volumes and unsupervised approvals succeeds. The JPMorgan note highlights that the upside hinges on rapid Cybercab production scaling, falling operating costs, and widespread unsupervised regulatory approvals. While the $320 billion figure represents a transformative scenario for a $94.83 billion FY2025 base, it reads more as a long-term projection than a booked line item. The near-term reality remains defined by margin compression and negative cash flow, making the execution of this capital-intensive strategy the critical variable for future stock performance.